Cargando…

FEV(1) inversely correlates with metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke exposure

BACKGROUND: Matrix metalloproteinases (MMPs) and C-reactive protein (CRP) are involved in chronic obstructive pulmonary disease (COPD) pathogenesis. The aim of the present work was to determine plasma concentrations of MMPs and CRP in COPD associated to biomass combustion exposure (BE) and tobacco s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montaño, Martha, Sansores, Raul H, Becerril, Carina, Cisneros, Jose, González-Avila, Georgina, Sommer, Bettina, Ochoa, Leticia, Herrera, Iliana, Ramírez-Venegas, Alejandra, Ramos, Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086695/ https://www.ncbi.nlm.nih.gov/pubmed/24980707 http://dx.doi.org/10.1186/1465-9921-15-74

Ejemplares similares

Reliability of FEV(1)/FEV(6) to Diagnose Airflow Obstruction Compared with FEV(1)/FVC: The PLATINO Longitudinal Study
por: Perez-Padilla, Rogelio, et al.
Publicado: (2013)

Fixed Cut-Off for FEV1/FEV6 and FEV6 in Detection of Obstructive and Restrictive Patterns
por: Aghili, Rokhsareh, et al.
Publicado: (2013)

Cut-off value of FEV(1)/FEV(6) as a surrogate for FEV(1)/FVC for detecting airway obstruction in a Korean population
por: Chung, Kyung Soo, et al.
Publicado: (2016)

Nanotechnology and Matrix Metalloproteinases in Cancer Diagnosis and Treatment
por: Gonzalez-Avila, Georgina, et al.
Publicado: (2022)

Genome organization and molecular characterization of the three Formica exsecta viruses—FeV1, FeV2 and FeV4
por: Dhaygude, Kishor, et al.
Publicado: (2019)

Utility of FEV(1)/FEV(6) index in patients with multimorbidity hospitalized for decompensation of chronic diseases
por: Komal, Shakeel, et al.
Publicado: (2019)

CX3CL1 and CX3CR1 could be a relevant molecular axis in the pathophysiology of idiopathic pulmonary fibrosis
por: Rivas-Fuentes, Selma, et al.
Publicado: (2020)

Forced Expiratory Volume in 6 s (FEV(6)) and FEV(1)/FEV(6) Values as a Viable Alternative for Forced Vital Capacity (FVC) and FEV(1)/FVC Values During Pregnancy in South East Nigeria: A Preliminary Study
por: Nwagha, U, et al.
Publicado: (2014)

Allergen bronchoprovocation: correlation between FEV(1) maximal percent fall and area under the FEV(1) curve and impact of allergen on recovery
por: Durr, Sarah-Marie, et al.
Publicado: (2023)

Increased Ratio of Matrix Metalloproteinase-9 (MMP-9)/Tissue Inhibitor Metalloproteinase-1 from Alveolar Macrophages in Chronic Asthma with a Fast Decline in FEV(1) at 5-Year Follow-up
por: Chung, Fu-Tsai, et al.
Publicado: (2019)

Variability of FEV(1) and Criterion for Acute Pulmonary Exacerbation
por: Jenkins, Bradlee A., et al.
Publicado: (2014)

Diagnosis, assessment, and phenotyping of COPD: beyond FEV(1)
por: Lange, Peter, et al.
Publicado: (2016)

Rate of Decline of FEV(1) as a Biomarker of Survival?
por: Papi, Alberto, et al.
Publicado: (2021)

Bronchodilator Response of FEV6 and FEV3 as Surrogates of Forced Vital Capacity
por: Mehrparvar, Amir Houshang, et al.
Publicado: (2014)

Factors Associated with the Expression of ACE2 in Human Lung Tissue: Pathological Evidence from Patients with Normal FEV(1) and FEV(1)/FVC
por: Bao, Wuping, et al.
Publicado: (2021)

Matrix Metalloproteinases and Stress Hormones in Lung Cancer Progression
por: Gonzalez-Avila, Georgina, et al.
Publicado: (2022)

Lower FEV(1) in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV(1), total IgE levels, and TSLP genotypes
por: Masuko, Hironori, et al.
Publicado: (2011)

A mathematical reason for FEV1/FVC dependence on age
por: Gólczewski, Tomasz, et al.
Publicado: (2012)

Association between 25-hydroxy vitamin D and lung function (FEV1, FVC, FEV1/FVC) in children and adults with asthma: A systematic review
por: Abi-Ayad, Meryem, et al.
Publicado: (2023)

The “Slow Horse Racing Effect” on Lung Function in Adult Life in Chronic Obstructive Pulmonary Disease Associated to Biomass Exposure
por: Ramírez-Venegas, Alejandra, et al.
Publicado: (2021)

Bacteriophages fEV-1 and fD1 Infect Yersinia pestis
por: Skurnik, Mikael, et al.
Publicado: (2021)

Comparison between reference values for FVC, FEV(1), and FEV(1)/FVC ratio in White adults in Brazil and those suggested by the Global Lung Function Initiative 2012
por: Pereira, Carlos Alberto de Castro, et al.
Publicado: (2014)

Cut-off value of FEV(1)/FEV(6) to determine airflow limitation using handheld spirometry in subjects with risk of chronic obstructive pulmonary disease
por: Hwang, Yong Il, et al.
Publicado: (2021)

Effect of Different Positions on FVC and FEV(1) Measurements of Asthmatic Patients
por: Melam, Ganeswara Rao, et al.
Publicado: (2014)

Inflammatory and immunological profiles in patients with COPD: relationship with FEV (1) reversibility
por: Queiroz, Cleriston Farias, et al.
Publicado: (2016)

Vitamin D supplementation improves FEV1 in patients of Bronchial Asthma
por: Babar, Muhammad Zafar Majeed, et al.
Publicado: (2017)

Obstructive sleep apnoea accelerates FEV(1) decline in asthmatic patients
por: Wang, Tsai-Yu, et al.
Publicado: (2017)

Low FEV1 Is Associated With Increased Risk Of Cachexia In COPD Patients
por: Mokari-Yamchi, Amin, et al.
Publicado: (2019)

Remote FEV1 Monitoring in Asthma Patients: A Pilot Study
por: Huang, Chengrui, et al.
Publicado: (2020)

Pulmonary function testing in COPD: looking beyond the curtain of FEV1
por: Kakavas, Sotirios, et al.
Publicado: (2021)

FVC, but not FEV(1,) is associated with clinical outcomes of asthma-COPD overlap
por: An, Tai Joon, et al.
Publicado: (2022)

Decline in FEV(1) and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency
por: Hiller, Adriana-Maria, et al.
Publicado: (2019)

Antimicrobial Peptides SLPI and Beta Defensin-1 in Sputum are Negatively Correlated with FEV(1)
por: Cane, Jennifer, et al.
Publicado: (2021)

Diagnostic accuracy of pre-bronchodilator FEV(1)/FEV(6) from microspirometry to detect airflow obstruction in primary care: a randomised cross-sectional study
por: van den Bemt, Lisette, et al.
Publicado: (2014)

Systematic review of the evidence relating FEV(1 )decline to giving up smoking
por: Lee, Peter N, et al.
Publicado: (2010)

Beyond FEV(1) in COPD: a review of patient-reported outcomes and their measurement
por: Jones, Paul, et al.
Publicado: (2012)

327 Transition from Cough Variant Asthma to Asthma With Reduced FEV1
por: Lee, June-Hyuk, et al.
Publicado: (2012)

Reference percentiles for FEV(1) and BMI in European children and adults with cystic fibrosis
por: Boëlle, Pierre-Yves, et al.
Publicado: (2012)

Risk factors for FEV(1) decline in mild COPD and high-risk populations
por: Chen, Shujing, et al.
Publicado: (2017)

Bronchial hyperresponsiveness in an adult population in Helsinki: decreased FEV(1), the main determinant
por: Juusela, Maria, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l052mvjapfo3464lhekojfrku1